CA
ICPT

Cetera Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Cetera Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,543
Closed -$206K – 982
2019
Q2 		$206K Buy
2,543
+17
+0.7% +$1.52K 0.01% 846
2019
Q1 		$283K Buy
+2,526
New +$276K 0.01% 655

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cetera Advisors's ICPT Position: Q3 2019 in Review

Cetera Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2019, closing a stake of 2,543 shares — an estimated $206K sold.

Cetera Advisors first reported a position in ICPT in Q1 2019 and held it in 2 quarters. The position peaked at $283K in Q1 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q3 2019.

  • Cetera Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Cetera Advisors sold 2,543 Intercept Pharmaceuticals, Inc. shares in Q3 2019, an estimated $206K.
  • Cetera Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2019 and held it in 2 quarters.
  • Cetera Advisors's Intercept Pharmaceuticals, Inc. position peaked at $283K in Q1 2019.
  • 188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2019.

Based on Cetera Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.